Azacytidine Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome: Day-Hospital Management Compared to Home Care Setting

Introduction Treatment with Hypometilating Agents (HMA) of unfit patients (pts) with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (HR-MDS) is often difficult in the standard Day-Hospital (DH) setting, due to the number of hospital admissions required and the frail clinica...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.4042-4042
Hauptverfasser:	Trapè, Giulio, De Angelis, Gioia, Morucci, Marco, Tarnani, Michela, De Gregoris, Cinzia, Di Veroli, Ambra, Panichi, Valentina, Topini, Giuseppe, Bassi, Loredana, Isidori, Raffaella, Poscente, Monica, Innocenti, Vincenza, Emanueli Cippitelli, Elisa, Talucci, Roberta, Bertelli, Silvia, Crocicchia, Alessandra, Lippi, Annalisa, Pezzuti, Giulia, Fuschino, Michela, Randi, Raffaella, Mastino, Cristina, Ciambella, Silvia, Pessina, Gloria, Montanaro, Marco, Latagliata, Roberto
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!